PATENT CLAIM ANALYSIS

Application Number: 15768025
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "210210"]

Abstract:
The invention relates to novel ferroportin inhibitors of the general formula (I) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia and hemochromatosis.

Claim (Index 9):
Compounds for the use according to any one of the preceding claims, wherein\n Z is an optionally substituted cyclic group Z-Cycl, selected from an optionally substituted 5-membered heteroaryl, forming a compound of the formula (IIa-a) wherein one or two further heteroatoms X (X 2 , X 3 , X 4 ) are present, and wherein\n X 2  is C or N; \n X 3  is C, N, S or O; and \n X 4  is C or N; \n with the proviso that in case of two further heteroatoms both are selected to be N or one is N and one (except X 2 ) is O; and wherein X 3  and X 4  with the meaning of C or N may carry a further substituent; and wherein R 1 , R 2 , R 3 , A 1 , A 2  and Ar have the meaning as defined in the preceding claims.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.25532
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15769148', '14310254', '15517528', '14007533', '15185186']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7892329615810337
- 35 USC 102 Novelty (BERT): 0.552882738579582
- Combined Prediction Score: 0.7655979392808886
- Mean Citation Score: 298.633386
- Max Citation Score: 422.5474
- Similarity Product: 322.4186565793395

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test